Ectopic pregnancy

Causes

There are several risk factors for ectopic pregnancies. However, in as many as one-third to one-half no risk factors can be identified. Risk factors include: pelvic inflammatory disease, infertility, use of an intrauterine device (IUD), previous exposure to diethylstilbestrol (DES), tubal surgery, intrauterine surgery (e.g. D&C), smoking, previous ectopic pregnancy, endometriosis, and tubal ligation. A previous induced abortion does not appear to increase the risk. The IUD does not increase the risk of ectopic pregnancy, but with an IUD if pregnancy occurs it is more likely to be ectopic than intrauterine. The risk of ectopic pregnancy after chlamydia infection is low. The exact mechanism through which chlamydia increases the risk of ectopic pregnancy is uncertain, though some research suggests that the infection can affect the structure of fallopian tubes.

Tube damage

Tubal pregnancy is when the egg is implanted in the fallopian tubes. Hair-like cilia located on the internal surface of the fallopian tubes carry the fertilized egg to the uterus. Fallopian cilia are sometimes seen in reduced numbers after an ectopic pregnancy, leading to a hypothesis that cilia damage in the fallopian tubes is likely to lead to an ectopic pregnancy. Women who smoke have a higher chance of an ectopic pregnancy in the fallopian tubes. Smoking leads to risk factors of damaging and destroying cilia. As cilia degenerate, the amount of time it takes for the fertilized egg to reach the uterus will increase. The fertilized egg, if it does not reach the uterus in time, will hatch from the non-adhesive zona pellucida and implant itself inside the fallopian tube, thus causing ectopic pregnancy.

Women with pelvic inflammatory disease (PID) have a high occurrence of ectopic pregnancy. This results from the build-up of scar tissue in the fallopian tubes, causing damage to the cilia. However, if both tubes were completely blocked, so that sperm and egg were physically unable to meet, then fertilization of the egg would naturally be impossible, and neither normal pregnancy nor ectopic pregnancy could occur. Intrauterine adhesions (IUA) present in Asherman's syndrome can cause ectopic cervical pregnancy or, if adhesions partially block access to the tubes via the ostia, ectopic tubal pregnancy. Asherman's syndrome usually occurs from intrauterine surgery, most commonly after D&C. Endometrial/pelvic/genital tuberculosis, another cause of Asherman's syndrome, can also lead to ectopic pregnancy as infection may lead to tubal adhesions in addition to intrauterine adhesions.

Tubal ligation can predispose to ectopic pregnancy. Reversal of tubal sterilization (tubal reversal) carries a risk for ectopic pregnancy. This is higher if more destructive methods of tubal ligation (tubal cautery, partial removal of the tubes) have been used than less destructive methods (tubal clipping). A history of a tubal pregnancy increases the risk of future occurrences to about 10%. This risk is not reduced by removing the affected tube, even if the other tube appears normal. The best method for diagnosing this is to perform an early ultrasound.

Endometriosis

Endometriosis is a disease in which cells similar to those of the endometrium, the tissue covering the inside of the uterus, grow outside the uterus. An embryo attaching to such lesions leads to an ectopic pregnancy. The results of a 30-year study of reproductive and pregnancy outcomes, involving 14,000+ women of childbearing age, were presented at the 2015 European Society of Human Reproduction and Embryology (ESHRE) annual congress. 39% of the study group had surgically confirmed endometriosis. Compared to their peers, the endometriosis subgroup had a 76% higher risk for miscarriage and a 270% higher risk for ectopic pregnancy. The higher risk of endometriosis was attributed to increased pelvic inflammation and structural and functional changes in the uterine lining.

Other

Although some investigations have shown that patients may be at higher risk for ectopic pregnancy with advancing age, it is believed that age is a variable that could act as a surrogate for other risk factors. Vaginal douching is thought by some to increase ectopic pregnancies. Women exposed to DES in utero (also known as "DES daughters") also have an elevated risk of ectopic pregnancy. However, DES has not been used since 1971 in the United States. It has also been suggested that pathologic generation of nitric oxide through increased iNOS production may decrease tubal ciliary beats and smooth muscle contractions and thus affect embryo transport, which may consequently result in ectopic pregnancy. Low socioeconomic status may also be a risk factor for ectopic pregnancy.

Diagnosis

An ectopic pregnancy should be considered as the cause of abdominal pain or vaginal bleeding in everyone who has a positive pregnancy test. The primary goal of diagnostic procedures in possible ectopic pregnancy is to triage according to risk rather than establishing pregnancy location.

Transvaginal ultrasonography

An ultrasound showing a gestational sac with the fetal heart in the fallopian tube has a very high specificity for ectopic pregnancy. It involves a long, thin transducer, covered with the conducting gel and a plastic/latex sheath, and inserted into the vagina. Transvaginal ultrasonography has a sensitivity of at least 90% for ectopic pregnancy. The diagnostic ultrasonographic finding in ectopic pregnancy is an adnexal mass that moves separately from the ovary. In around 60% of cases, it is an inhomogeneous or a noncystic adnexal mass, sometimes known as the "blob sign". It is generally spherical, but a more tubular appearance may be seen in the case of hematosalpinx. This sign has been estimated to have a sensitivity of 84% and a specificity of 99% in diagnosing ectopic pregnancy. In the study estimating these values, the blob sign had a positive predictive value of 96% and a negative predictive value of 95%. The visualization of an empty extrauterine gestational sac is sometimes known as the "bagel sign", and is present in around 20% of cases. In another 20% of cases, there is visualization of a gestational sac containing a yolk sac or an embryo. Ectopic pregnancies where there is visualization of cardiac activity are sometimes termed "viable ectopic".

The combination of a positive pregnancy test and the presence of what appears to be a normal intrauterine pregnancy does not exclude ectopic pregnancy, since there may be either a heterotopic pregnancy or a "pseudosac", which is a collection of within the endometrial cavity that may be seen in up to 20% of women.

A small amount of anechogenic-free fluid in the recto-uterine pouch is commonly found in both intrauterine and ectopic pregnancies. The presence of echogenic fluid is estimated at between 28 and 56% of women with an ectopic pregnancy, and strongly indicates the presence of hemoperitoneum. However, it does not necessarily result from tubal rupture but is commonly a result from leakage from the distal tubal opening. As a rule of thumb, the finding of free fluid is significant if it reaches the fundus or is present in the vesico-uterine pouch. A further marker of serious intra-abdominal bleeding is the presence of fluid in the hepatorenal recess of the subhepatic space.

As of 2014, Doppler ultrasonography is not considered to significantly contribute to the diagnosis of ectopic pregnancy.

A common misdiagnosis of a normal intrauterine pregnancy is when the pregnancy is implanted laterally in an arcuate uterus, potentially being misdiagnosed as an interstitial pregnancy.

Ultrasonography and β-hCG

Where no intrauterine pregnancy (IUP) is seen on ultrasound, measuring β-human chorionic gonadotropin (β-hCG) levels may aid in the diagnosis. The rationale is that a low β-hCG level may indicate that the pregnancy is intrauterine but too small to be visible on ultrasonography. While some physicians consider that the threshold where an intrauterine pregnancy should be visible on transvaginal ultrasound is around 1500 mIU/mL of β-hCG, a review in the JAMA Rational Clinical Examination Series showed that there is no single threshold for the β-human chorionic gonadotropin that confirms an ectopic pregnancy. Instead, the best test for a pregnant woman is a high-resolution transvaginal ultrasound. The presence of an adnexal mass in the absence of an intrauterine pregnancy on transvaginal sonography increases the likelihood of an ectopic pregnancy 100-fold (LR+ 111). When there are no adnexal abnormalities on transvaginal sonography, the likelihood of an ectopic pregnancy decreases (LR- 0.12). An empty uterus with levels higher than 1500 mIU/mL may be evidence of an ectopic pregnancy, but it may also be consistent with an intrauterine pregnancy, which is too small to be seen on ultrasound. If the diagnosis is uncertain, it may be necessary to wait a few days and repeat the blood work. This can be done by measuring the β-hCG level approximately 48 hours later and repeating the ultrasound. The serum hCG ratios and logistic regression models appear to be better than absolute single serum hCG level. If the β-hCG falls on repeat examination, this strongly suggests a spontaneous abortion or rupture. The fall in serum hCG over 48 hours may be measured as the hCG ratio, which is calculated as: ${\displaystyle hCGratio=\frac{hCGat48h}{hCGat0h}}$

An hCG ratio of 0.87 – a decrease in hCG of 13% over 48 hours – has a sensitivity of 93% and specificity of 97% for predicting a failing pregnancy of unknown location (PUL). The majority of cases of ectopic pregnancy will have serial serum hCG levels that increase more slowly than would be expected with an IUP (known as a suboptimal rise), or decrease more slowly than would be expected with a failing PUL. However, up to 20% of cases of ectopic pregnancy have serum hCG doubling times similar to that of an IUP, and around 10% of EP cases have hCG patterns similar to a failing PUL.

Other methods

Direct examination

A laparoscopy or laparotomy can also be performed to confirm an ectopic pregnancy visually. This is generally reserved for women presenting with signs of an acute abdomen and hypovolemic shock. Often, if a tubal abortion or tubal rupture has occurred, it is difficult to find the pregnancy tissue. A laparoscopy in a very early ectopic pregnancy rarely shows a normal-looking fallopian tube.

Culdocentesis

Culdocentesis, in which fluid is retrieved from the space separating the vagina and rectum, is a less commonly performed test that may be used to look for internal bleeding. In this test, a needle is inserted into the space at the very top of the vagina, behind the uterus, and in front of the rectum. Any blood or fluid found may have been derived from a ruptured ectopic pregnancy.

Progesterone levels

Progesterone levels of less than 20 nmol/L have a high predictive value for failing pregnancies, whilst levels over 25 nmol/L are likely to predict viable pregnancies, and levels over 60 nmol/L are strongly so. This may help identify failing PUL that are at low risk and thereby require less follow-up. Inhibin A may also be useful for predicting spontaneous resolution of PUL, but is not as effective as progesterone for this purpose.

Mathematical models

There are various mathematical models, such as logistic regression models and Bayesian networks, for the prediction of PUL outcomes based on multiple parameters. Mathematical models also aim to identify PULs that are low risk, that is, failing PULs and IUPs.

Dilation and curettage

Dilation and curettage (D&C) is sometimes used to diagnose pregnancy location to differentiate between an EP and a non-viable IUP in situations where a viable IUP can be ruled out. Specific indications for this procedure include either of the following:

• No visible IUP on transvaginal ultrasonography with a serum hCG of more than 2000 mIU/mL.
• An abnormal rise in hCG level. A rise of 35% over 48 hours is proposed as the minimal rise consistent with a viable intrauterine pregnancy.
• An abnormal fall in hCG level, defined as one of less than 20% in two days.

Classification

Tubal pregnancy

The vast majority of ectopic pregnancies implant in the fallopian tube. Pregnancies can grow in the fimbrial end (5% of all ectopic pregnancies), the ampullary section (80%), the isthmus (12%), and the cornual and interstitial part of the tube (2%). Mortality of a tubal pregnancy at the isthmus or within the uterus (interstitial pregnancy) is higher as there is increased vascularity that may result more likely in sudden major internal bleeding. A review published in 2010 supports the hypothesis that tubal ectopic pregnancy is caused by a combination of retention of the embryo within the fallopian tube due to impaired embryo-tubal transport and alterations in the tubal environment allowing early implantation to occur.

Nontubal ectopic pregnancy

Two percent of ectopic pregnancies occur in the ovary, cervix, or are intra-abdominal. Transvaginal ultrasound examination is usually able to detect a cervical pregnancy. An ovarian pregnancy is differentiated from a tubal pregnancy by the Spiegelberg criteria.

While a fetus of ectopic pregnancy is typically not viable, very rarely, live babies have been delivered from abdominal pregnancy or C-section scar ectopic pregnancy. In the former situation, the placenta sits on the intra-abdominal organs or the peritoneum and has found sufficient blood supply. This is generally bowel or mesentery, but other sites, such as the renal (kidney), liver or hepatic (liver) artery, or even the aorta, have been described. Support to near viability has occasionally been described, but even in Third World countries, the diagnosis is most commonly made at 16 to 20 weeks' gestation. Such a fetus would have to be delivered by laparotomy. Maternal morbidity and mortality from extrauterine pregnancy are high, as attempts to remove the placenta from the organs to which it is attached usually lead to uncontrollable bleeding from the attachment site. If the organ to which the placenta is attached is removable, such as a section of the bowel, then the placenta should be removed together with that organ. This is such a rare occurrence that true data is unavailable, and reliance must be made on anecdotal reports. However, the vast majority of abdominal pregnancies require intervention well before fetal viability because of the risk of bleeding.

With the increase in Cesarean sections performed worldwide, Cesarean section ectopic pregnancies (CSP) are rare, but becoming more common. The incidence of CSP is not well known; however, there have been estimates based on different populations of 1:1800–1:2216. CSP are characterized by abnormal implantation into the scar from a previous cesarean section, and allowed to continue can cause serious complications such as uterine rupture and hemorrhage. Patients with CSP generally present without symptoms; symptoms can include vaginal bleeding that may or may not be associated with pain. The diagnosis of CSP is made by ultrasound and four characteristics are noted: (1) Empty uterine cavity with bright hyperechoic endometrial stripe (2) Empty cervical canal (3) Intrauterine mass in the anterior part of the uterine isthmus, and (4) Absence of the anterior uterine muscle layer, and/or absence or thinning between the bladder and gestational sac, measuring less than 5 mm. Given the rarity of the diagnosis, treatment options tend to be described in case reports and series, ranging from medical with methotrexate or KCl to surgical with dilation and curettage, uterine wedge resection, or hysterectomy. A double-balloon catheter technique has also been described, allowing for uterine preservation. The recurrence risk for CSP is unknown, and early ultrasound in the next pregnancy is recommended.

Heterotopic pregnancy

In rare cases of ectopic pregnancy, there may be two fertilized eggs, one outside the uterus and the other inside. This is called a heterotopic pregnancy. Often, the intrauterine pregnancy is discovered later than the ectopic, mainly because of the painful emergency nature of ectopic pregnancies. Since ectopic pregnancies are normally discovered and removed very early in the pregnancy, an ultrasound may not find the additional pregnancy inside the uterus. When hCG levels continue to rise after the removal of the ectopic pregnancy, there is a chance that a pregnancy inside the uterus is still viable. This is normally discovered through an ultrasound.

Although rare, heterotopic pregnancies are becoming more common, likely due to increased use of IVF. The survival rate of the uterine fetus of a heterotopic pregnancy is around 70%.

Rudimentary horn pregnancy

A pregnancy in a rudimentary horn refers to a rare and life-threatening condition that occurs when a fertilized egg implants inside the small rudimentary horn of a unicornuate uterus, which is a type of congenital uterine abnormality caused by the incomplete development of one of the Müllerian ducts. This type of ectopic pregnancy is often results in rupture of the rudimentary horn between 10 and 15 weeks of gestation, leading to a high risk of morbidity and mortality.

Persistent ectopic pregnancy

A persistent ectopic pregnancy refers to the continuation of trophoblastic growth after a surgical intervention to remove an ectopic pregnancy. After a conservative procedure that attempts to preserve the affected fallopian tube, such as a salpingotomy, in about 15–20%, the major portion of the ectopic growth may have been removed, but some trophoblastic tissue, perhaps deeply embedded, has escaped removal and continues to grow, generating a new rise in hCG levels. After weeks, this may lead to new clinical symptoms, including bleeding. For this reason, hCG levels may have to be monitored after the removal of an ectopic pregnancy to ensure their decline, also methotrexate can be given at the time of surgery prophylactically.

Pregnancy of unknown location

Pregnancy of unknown location (PUL) is the term used for a pregnancy where there is a positive pregnancy test but no pregnancy has been visualized using transvaginal ultrasonography. Specialized early pregnancy departments have estimated that between 8% and 10% of women attending for an ultrasound assessment in early pregnancy will be classified as having a PUL. The true nature of the pregnancy can be an ongoing viable intrauterine pregnancy, a failed pregnancy, an ectopic pregnancy or rarely a persisting PUL.

Because of frequent ambiguity on ultrasonography examinations, the following classification is proposed:

In women with a pregnancy of unknown location, between 6% and 20% have an ectopic pregnancy. In cases of pregnancy of unknown location and a history of heavy bleeding, it has been estimated that approximately 6% have an underlying ectopic pregnancy. Between 30% and 47% of women with pregnancy of unknown location are ultimately diagnosed with an ongoing intrauterine pregnancy, of which the majority (50–70%) will be found to have failed pregnancies where the location is never confirmed.

Persisting PUL is where the hCG level does not spontaneously decline, and no intrauterine or ectopic pregnancy is identified on follow-up transvaginal ultrasonography. A persisting PUL is likely either a small ectopic pregnancy that has not been visualized or a retained trophoblast in the endometrial cavity. Treatment should only be considered when a potentially viable intrauterine pregnancy has been definitively excluded. A treated persistent PUL is defined as one managed medically (generally with methotrexate) without confirmation of the location of the pregnancy, such as by ultrasound, laparoscopy, or uterine evacuation. A resolved persistent PUL is defined as serum hCG reaching a non-pregnant value (generally less than 5 IU/L) after expectant management, or after uterine evacuation without evidence of chorionic villi on histopathological examination. In contrast, a relatively low and unresolving level of serum hCG indicates the possibility of an hCG-secreting tumor.

Differential diagnosis

Other conditions that cause similar symptoms include: miscarriage, ovarian torsion, acute appendicitis, ruptured ovarian cyst, kidney stone, and pelvic inflammatory disease, among others.

Treatment

Expectant management

Most women with a PUL are followed up with serum hCG measurements and repeat TVS examinations until a final diagnosis is confirmed. Low-risk cases of PUL that appear to be failing pregnancies may be followed up with a urinary pregnancy test after two weeks and get subsequent telephone advice. Low-risk cases of PUL that are likely intrauterine pregnancies may have another TVS in two weeks to assess viability. High-risk cases of PUL require further assessment, either with a TVS within 48 h or additional hCG measurement.

Medical

Early treatment of ectopic pregnancy with methotrexate is a viable alternative to surgical treatment which was developed in the 1980s. If administered early in the pregnancy, methotrexate terminates the growth of the developing embryo; the developing embryo may then be either resorbed by the woman's body or pass with a menstrual period. Contraindications include ectopic embryonic mass > 3.5 cm and evidence of ruptured fallopian tube, as well as renal or hepatic dysfunction.

Also, it may lead to the inadvertent termination of an undetected intrauterine pregnancy or severe abnormality in any surviving pregnancy. Therefore, it is recommended that methotrexate should only be administered when hCG has been serially monitored with a rise of less than 35% over 48 hours, which practically excludes a viable intrauterine pregnancy.

For nontubal ectopic pregnancy, evidence from randomized clinical trials in women with CSP is uncertain regarding treatment success, complications and side effects of methotrexate compared with surgery (uterine arterial embolization or uterine arterial chemoembolization).

The United States uses a multi-dose protocol of methotrexate (MTX), which involves four doses of intramuscular MTX along with an intramuscular injection of folinic acid to protect cells from the effects of the drug and to reduce side effects. In France, the single-dose protocol is followed, but a single dose has a greater chance of failure.

Surgery

If bleeding has already occurred, surgical intervention may be necessary. However, whether to pursue surgical intervention is an often difficult decision in a stable patient with minimal evidence of a blood clot on ultrasound.

Surgeons use laparoscopy or laparotomy to gain access to the pelvis and can either incise the affected fallopian tube and remove only the pregnancy (salpingostomy) or remove the affected tube with the pregnancy (salpingectomy). The first successful surgery for an ectopic pregnancy was performed by Robert Lawson Tait in 1883. It is estimated that an acceptable rate of PULs that eventually undergo surgery is between 0.5 and 11%. Women who undergo salpingectomy and salpingostomy have a similar recurrent ectopic pregnancy rate of 5% and 8%, respectively. Additionally, their intrauterine pregnancy rates are also similar, 56% and 61%.

Autotransfusion of a woman's own blood as drained during surgery may be useful in those who have a lot of bleeding into their abdomen.

No technique exists to re-implant an ectopic embryo in the uterus – all interventions, whether surgical or pharmaceutical, result in the termination of the ectopic pregnancy. Published reports that a reimplanted embryo survived to birth were debunked as false.

Prognosis

When ectopic pregnancies are treated, the prognosis for the mother is very good in Western countries; maternal death is rare, although treatment nearly always requires the removal of the nonviable fetus. For instance, in the UK, between 2003 and 2005, there were 32,100 ectopic pregnancies resulting in 10 maternal deaths (meaning that 1 in 3,210 women with an ectopic pregnancy died, or around 0.03% case fatality rate). In 2006–2008 the UK Confidential Enquiry into Maternal Deaths found that ectopic pregnancy was the cause of 6 maternal deaths out of 2.3 million pregnancies in that period (0.26/100,000 pregnancies).

In the developing world, however, the death rate is substantially higher at around 1–3% case fatality rate. The burden of ectopic pregnancy is much higher in developing countries, causing the deaths of 3478 (95% confidence interval: 2849 to 4187) people in low income countries in 2019, or 0.68 (95% CI: 0.56 to 0.82) per 100,000 population, and was responsible for the loss of 37.69 (95% CI: 30.83 to 45.33) disability adjusted life years per 100,000, indicating that it is a significant cause of death and disease burden among women of child-bearing age in these countries.

In women who have had an ectopic pregnancy, the risk of another one in the next pregnancy is around 10%.

Future fertility

Fertility following ectopic pregnancy depends upon several factors, the most important of which is a prior history of infertility. The treatment choice does not play a major role; a randomized study in 2013 concluded that the rates of intrauterine pregnancy two years after treatment of ectopic pregnancy are approximately 64% with radical surgery, 67% with medication, and 70% with conservative surgery. In comparison, the cumulative pregnancy rate of women under 40 years of age in the general population over two years is over 90%.

Methotrexate does not affect future fertility treatments. The number of oocytes that were retrieved before and after treatment with methotrexate does not change.

In case of ovarian ectopic pregnancy, the risk of subsequent ectopic pregnancy or infertility is low.

There is no evidence that massage improves fertility after an ectopic pregnancy.

Epidemiology

The rate of ectopic pregnancy is between about 1% and 2% of live births in developed countries, though it is as high as 4% in pregnancies involving assisted reproductive technology. Between 93% and 97% of ectopic pregnancies are located in a fallopian tube. Of these, in turn, 13% are located in the isthmus, 75% are located in the ampulla, and 12% in the fimbriae. Ectopic pregnancy is responsible for 6% of maternal deaths during the first trimester of pregnancy making it the leading cause of maternal death during this stage of pregnancy.

Between 5% and 42% of women seen for ultrasound assessment with a positive pregnancy test have a pregnancy of unknown location, that is, a positive pregnancy test but no pregnancy visualized at transvaginal ultrasonography. Between 6% and 20% of pregnancies of unknown location are subsequently diagnosed with actual ectopic pregnancy.

Society and culture

Salpingectomy as a treatment for ectopic pregnancy is one of the common cases when the principle of double effect can be used to justify accelerating the death of the embryo by doctors and patients opposed to outright abortions.

In the Catholic Church, there are moral debates on certain treatments. A significant number of Catholic moralists consider the use of methotrexate and the salpingostomy procedure to be not "morally permissible" because they destroy the embryo; however, situations are considered differently in which the mother's health is endangered, and the whole fallopian tube with the developing embryo inside is removed.

Organizations exist that provide information and support to help those who experience ectopic pregnancy. Studies show that people can experience post-traumatic stress, depression, and anxiety for which they would need specialist therapies. Partners can also experience post-traumatic stress.

History

Until 1888, surgical treatment of ruptured ectopic pregnancies was either not considered at all, or did not save the woman's life due to blood loss. Surgeon Robert Lawson Tait, who performed the first successful surgery, initially refused to consider surgery; however, after participating in the autopsy of a young woman who died of a ruptured ectopic pregnancy, he determined how it could be surgically repaired. His first patient died, but most of the subsequent ones survived.

Live birth

The vast majority of ectopic pregnancies cannot produce a viable fetus or a live birth, as the fetus cannot find a sufficient blood supply and its growth puts the mother's life at risk. In very rare cases, the fetus can implant in a location where it poses little risk to the mother and finds sufficient blood supply to grow to term. In these cases, the ectopic pregnancy can lead to a live baby surgically delivered by laparotomy.

In July 1999, Lori Dalton gave birth by caesarean section in Ogden, Utah, United States, to a healthy baby girl, Sage, who had developed outside of the uterus. Previous ultrasounds had not discovered the problem, and the doctor performing the caesarean was surprised to find the baby "within the amniotic membrane outside the womb". The baby had a solid blood supply outside the womb due to the presence of a uterine fibroid on the outer wall of the uterus, and suffered no ill effects as a result.

In September 1999, an English woman, Jane Ingram (age 32), gave birth to triplets: Olivia, Mary, and Ronan, with an extrauterine fetus (Ronan) below the womb and twins in the womb. All three survived. The twins in the womb were taken out first.

In May 2003, a South African woman, Cwayita Ncise (age 20), gave birth, via surgery, to healthy baby girl, Nhlahla, where the placenta had attached to the liver. The placenta and amniotic sac were left inside her, as it was expected they would be reabsorbed, and since an operation to remove them would have placed her life at risk.

On May 29, 2008, an Australian woman, Meera Thangarajah (age 34), who had an ectopic pregnancy in the ovary, gave birth to a healthy full-term 6-pound-3-ounce (2.8 kg) baby girl, Durga, via caesarean section. She had no problems or complications during the 38‑week pregnancy.

Animals

Ectopic gestation exists in mammals other than humans. In sheep, it can go to term, with mammary preparation to parturition, and expulsion efforts. The fetus can be removed by caesarean section.